ARCHIVES

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

This article is from The Cancer Letter archive.

Vol. 31 No. 30 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

RFAs In Bladder, Prostate, Ok’d By DCBDC Advisors

March 1, 1991

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

In Brief: Switch To Grants Did Not hurt Virus Research, Watson says; The Field Is Healthy, Well Funded

October 2, 1981

NIH Awards 24 More Grants For Women’s Health Initiative

October 14, 1994

Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever

October 31, 2014

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012